Atezolizumab and carboplatin in metastatic lobular breast cancer
The GELATO trial shows the feasibility of trials specifically designed for invasive lobular breast cancer and demonstrate antitumor activity of PD-L1 blockade and carboplatin
Day: June 5, 2023